Cover Image
Market Research Report

Cell Surface Markers Market by Product (Antibody, PCR Array), Source (Mice, Rat), Cell Type (T cells, B cells, NK cell), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)), and End User (Hospitals) - Global Forecast to 2023

Published by MarketsandMarkets Product code 759863
Published Content info 141 Pages
Delivery time: 1-2 business days
Price
Back to Top
Cell Surface Markers Market by Product (Antibody, PCR Array), Source (Mice, Rat), Cell Type (T cells, B cells, NK cell), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)), and End User (Hospitals) - Global Forecast to 2023
Published: December 18, 2018 Content info: 141 Pages
Description

"High global prevalence of cancer is expected to drive the overall growth of the cell surface markers market"

The cell surface markers market is projected to reach USD 769 million by 2023 from USD 520 million in 2018, at a CAGR of 8.1% during the forecast period. The growth of this market is majorly driven by the high global prevalence of cancer, increasing funding for life sciences research, and growth in stem cell and neurobiology research. On the other hand, factors such as the costly and time-intensive antibody development process may hinder the growth of this market in the coming years.

"Antibodies segment is expected to grow at the highest CAGR during the forecast period"

Based on product type, the cell surface markers market is segmented into antibodies and PCR arrays. The antibodies segment is expected to account for a larger share of the market in 2018 as well as grow at a higher CAGR during the forecast period. This can majorly be attributed to the increasing demand for accurate and reliable antibodies by research communities.

"T cell surface markers segment is expected to account for the largest share of the cell surface markers market, by cell type, during the forecast period"

Based on cell type, the cell surface markers market is segmented into T cell surface markers, B cell surface markers, NK cell surface markers, monocyte cell surface markers, and other cell types. In 2018, the T cell surface markers segment is expected to account for the largest share of the cell surface markers market. The large share of this segment is attributed to the high and growing use of T cell surface markers in research and diagnostics.

"North America to dominate the market during the forecast period"

In 2018, North America is expected to account for the largest share of the cell surface markers market. North America has a well-established pharmaceuticals sector and currently dominates the cell surface markers market due to the increasing demand for the effective diagnosis and treatment of chronic diseases. Also, the adoption rate of cell surface markers for disease diagnostics, majorly for cancer diagnosis, is high in North America. This is one of the major factors supporting the growth of this regional market. The Asian market, on the other hand, is expected to grow at the highest CAGR during the forecast period. Factors such as government initiatives to boost biotechnology and pharmaceutical industries and increasing life sciences research activities are supporting the growth of the cell surface markers market in Asia.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1: 55%, Tier 2: 20%, Tier 3: 25%
  • By Designation - C-level: 58%, D-level: 19%, Others: 23%
  • By Region - North America: 40%, Europe: 30%, Asia: 10%, RoW: 20%

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific (US)
  • QIAGEN N.V. (Netherlands)
  • Becton, Dickinson and Company (US)
  • F. Hoffman-La Roche (Switzerland)
  • Bio-Rad Laboratories (US)
  • Danaher Corporation (US)
  • Abcam (UK)
  • Genscript (China)
  • Biolegend (US)
  • B. Braun Melsungen AG (Germany)
  • Cell Signaling Technology (US)
  • Merck KGaA (Germany)
  • Bio-Techne (US)

Research Coverage:

This report provides a detailed picture of the global cell surface markers market. It aims at estimating the size and future growth potential of the market across different segments, such as product type, antibodies by source, cell type, application, end user, and region. The report also includes an in-depth competitive analysis of key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them the closest approximations of the revenue numbers for the overall cell surface markers market and its subsegments. Also, this report will help stakeholders to better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

Table of Contents
Product Code: BT 6815

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKET COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DESIGN
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CELL SURFACE MARKERS: MARKET OVERVIEW
  • 4.2. CELL SURFACE MARKERS MARKET, BY PRODUCT
  • 4.3. CELL SURFACE MARKERS MARKET, BY CELL TYPE (2018)
  • 4.4. CELL SURFACE MARKERS MARKET, BY APPLICATION, 2018 VS. 2023(USD MILLION)
  • 4.5. CELL SURFACE MARKERS MARKET, BY END USER, 2018 VS. 2023(USD MILLION)
  • 4.6. CELL SURFACE MARKERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing funding for life science research
      • 5.2.1.2. High global prevalence of cancer
      • 5.2.1.3. Growth in stem cell and neurobiology research
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Costly and time-intensive antibody development process
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. High growth opportunities in emerging markets

6. CELL SURFACE MARKERS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. ANTIBODIES
    • 6.2.1. ANTIBODIES TO DOMINATE THE CELL SURFACE MARKER PRODUCTS MARKET DURING THE FORECAST PERIOD
  • 6.3. PCR ARRAYS
    • 6.3.1. PCR ARRAY PROFILES THE EXPRESSION OF GENES RELEVANT TO RESEARCH AT THE CELL SURFACE MARKER LEVEL

7. CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE

  • 7.1. INTRODUCTION
  • 7.2. MICE
    • 7.2.1. MICE ARE THE MOST PREFERRED HOSTS FOR RESEARCH-USE CELL SURFACE ANTIBODY PRODUCTION
  • 7.3. RATS
    • 7.3.1. RATS ARE THE SECOND-MOST-WIDELY USED ANIMAL HOSTS FOR MONOCLONAL ANTIBODY PRODUCTION
  • 7.4. OTHER SOURCES

8. CELL SURFACE MARKERS MARKET, BY CELL TYPE

  • 8.1. INTRODUCTION
  • 8.2. T CELL SURFACE MARKERS
    • 8.2.1. T CELL SURFACE MARKERS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018
  • 8.3. B CELL SURFACE MARKERS
    • 8.3.1. B CELL SURFACE MARKERS ARE USED TO IDENTIFY B CELLS FROM HETEROGENEOUS SAMPLES
  • 8.4. NK CELL SURFACE MARKERS
    • 8.4.1. NK CELL SURFACE MARKERS IDENTIFY NK CELLS AT VARIOUS STAGES OF DEVELOPMENT
  • 8.5. MONOCYTE CELL SURFACE MARKERS
    • 8.5.1. MONOCYTES PLAY A CRITICAL ROLE IN MAINTAINING OVERALL HEALTH
  • 8.6. OTHER CELL TYPES

9. CELL SURFACE MARKERS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. RESEARCH APPLICATIONS
    • 9.2.1. DRUG DISCOVERY
      • 9.2.1.1. Cell surface markers play an important role in guiding decisions in every phase of drug development
    • 9.2.2. IMMUNOLOGY
      • 9.2.2.1. The assessment of cell surface antigens using cell surface markers is an important field of immunological research
    • 9.2.3. STEM CELL RESEARCH
      • 9.2.3.1. Cell surface biomarkers are used to characterize, isolate, and analyze stem cells
    • 9.2.4. OTHER RESEARCH APPLICATIONS
  • 9.3. CLINICAL APPLICATIONS
    • 9.3.1. ONCOLOGY
      • 9.3.1.1. Cell surface markers are an emerging diagnostic tool in the field of hematological oncology.
    • 9.3.2. IMMUNODEFICIENCY DISEASES
      • 9.3.2.1. Cell surface markers are used for the detection of HIV infections
    • 9.3.3. OTHER CLINICAL APPLICATIONS

10. CELL SURFACE MARKERS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. ACADEMIC & RESEARCH INSTITUTES
    • 10.2.1. ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS OF THE CELL SURFACE MARKERS MARKET
  • 10.3. HOSPITALS & CLINICAL TESTING LABORATORIES
    • 10.3.1. HOSPITALS & CLINICAL TESTING LABORATORIES USE CELL SURFACE MARKERS FOR THE DIAGNOSIS OF VARIOUS DISEASES
  • 10.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.4.1. PATENT EXPIRATION OF BLOCKBUSTER DRUGS TO DRIVE THE GROWTH OF THE CELL MARKERS MARKET FOR THIS END-USER SEGMENT

11. CELL SURFACE MARKERS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. US
      • 11.2.1.1. High prevalence of chronic diseases
      • 11.2.1.2. Favorable funding for precision medicine research activities
    • 11.2.2. CANADA
      • 11.2.2.1. Availability of research funding
      • 11.2.2.2. Increasing prevalence of cancer
  • 11.3. EUROPE
    • 11.3.1. GERMANY
      • 11.3.1.1. Availability of funding driving the number of research activities
      • 11.3.1.2. Large-scale outsourcing of clinical diagnostic testing by hospitals to commercial service providers
    • 11.3.2. FRANCE
      • 11.3.2.1. Presence of a large biotechnology industry
      • 11.3.2.2. Government initiatives to boost research and development activities
    • 11.3.3. UK
      • 11.3.3.1. Government initiatives to strengthen academic research
      • 11.3.3.2. Increasing incidence and prevalence of chronic and infectious diseases
    • 11.3.4. ROE
  • 11.4. ASIA
  • 11.5. ROW

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET RANKING ANALYSIS
  • 12.3. COMPETITIVE SCENARIO
    • 12.3.1. PARTNERSHIPS AND AGREEMENTS (2016-2018)
    • 12.3.2. PRODUCT LAUNCHES (2016-2018)
    • 12.3.3. ACQUISITIONS (2016-2018)
    • 12.3.4. EXPANSIONS (2016-2018)

13. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1. THERMO FISHER SCIENTIFIC
  • 13.2. BECTON, DICKINSON AND COMPANY
  • 13.3. ABCAM
  • 13.4. QIAGEN N.V.
  • 13.5. F. HOFFMAN-LA ROCHE
  • 13.6. BIO-RAD LABORATORIES
  • 13.7. DANAHER CORPORATION
  • 13.8. GENSCRIPT
  • 13.9. BIOLEGEND
  • 13.10. CELL SIGNALING TECHNOLOGY
  • 13.11. BIO-TECHNE
  • 13.12. MERK KGAA

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. DISCUSSION GUIDE
  • 14.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3. AVAILABLE CUSTOMIZATIONS
  • 14.4. RELATED REPORTS
  • 14.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL CANCER INCIDENCE, 2018 VS. 2025
  • TABLE 2: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 3: CELL SURFACE MARKER ANTIBODIES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 4: CELL SURFACE MARKER PCR ARRAYS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 5: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016-2023 (USD MILLION)
  • TABLE 6: CELL SURFACE MARKER ANTIBODIES MARKET FOR MICE, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 7: CELL SURFACE MARKER ANTIBODIES MARKET FOR RATS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: CELL SURFACE MARKER ANTIBODIES MARKET FOR OTHER SOURCES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 9: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 10: T CELL SURFACE MARKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: B CELL SURFACE MARKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 12: NK CELL SURFACE MARKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: MONOCYTE CELL SURFACE MARKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 14: CELL SURFACE MARKERS MARKET FOR OTHER CELL TYPES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 15: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 16: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 17: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 18: CELL SURFACE MARKERS MARKET FOR DRUG DISCOVERY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 19: CELL SURFACE MARKERS MARKET FOR IMMUNOLOGY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: CELL SURFACE MARKERS MARKET FOR STEM CELL RESEARCH, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 21: CELL SURFACE MARKERS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 22: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 23: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 24: CELL SURFACE MARKERS MARKET FOR ONCOLOGY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 25: CELL SURFACE MARKERS MARKET FOR IMMUNODEFICIENCY DISEASES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: CELL SURFACE MARKERS MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 27: CELL SURFACE MARKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 28: CELL SURFACE MARKERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 29: CELL SURFACE MARKERS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 30: CELL SURFACE MARKERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 31: CELL SURFACE MARKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 32: NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 33: NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 34: NORTH AMERICA: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016-2023 (USD MILLION)
  • TABLE 35: NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 36: NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 37: NORTH AMERICA: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 38: NORTH AMERICA: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 39: NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 40: US: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 41: US: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016-2023 (USD MILLION)
  • TABLE 42: US: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 43: US: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 44: US: CELL SURFACE MARKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 45: CANADA: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 46: CANADA: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016-2023 (USD MILLION)
  • TABLE 47: CANADA: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 48: CANADA: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 49: CANADA: CELL SURFACE MARKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 50: EUROPE: CELL SURFACE MARKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 51: EUROPE: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 52: EUROPE: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016-2023 (USD MILLION)
  • TABLE 53: EUROPE: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 54: EUROPE: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 55: EUROPE: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 56: EUROPE: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 57: EUROPE: CELL SURFACE MARKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 58: GERMANY: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 59: GERMANY: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016-2023 (USD MILLION)
  • TABLE 60: GERMANY: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 61: GERMANY: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 62: GERMANY: CELL SURFACE MARKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 63: FRANCE: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 64: FRANCE: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016-2023 (USD MILLION)
  • TABLE 65: FRANCE: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 66: FRANCE: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 67: FRANCE: CELL SURFACE MARKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 68: UK: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 69: UK: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016-2023 (USD MILLION)
  • TABLE 70: UK: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 71: UK: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 72: UK: CELL SURFACE MARKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 73: ROE: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 74: ROE: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016-2023 (USD MILLION)
  • TABLE 75: ROE: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 76: ROE: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 77: ROE: CELL SURFACE MARKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 78: ASIA: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 79: ASIA: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016-2023 (USD MILLION)
  • TABLE 80: ASIA: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 81: ASIA: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 82: ASIA: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 83: ASIA: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 84: ASIA: CELL SURFACE MARKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 85: ROW: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 86: ROW: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016-2023 (USD MILLION)
  • TABLE 87: ROW: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016-2023 (USD MILLION)
  • TABLE 88: ROW: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 89: ROW: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 90: ROW: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 91: ROW: CELL SURFACE MARKERS MARKET, BY END USER, 2016-2023 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: CELL SURFACE MARKER MARKET SEGMENTATION
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
  • FIGURE 7: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE
  • FIGURE 8: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: CELL SURFACE MARKERS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE CELL SURFACE MARKERS MARKET
  • FIGURE 12: HIGH GLOBAL BURDEN OF CANCER & INCREASING FUNDING FOR LIFE SCIENCE RESEARCH ARE DRIVING THE GROWTH OF THE CELL SURFACE MARKERS MARKET
  • FIGURE 13: ANTIBODIES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 14: T CELL SURFACE MARKERS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018
  • FIGURE 15: CLINICAL APPLICATIONS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: ACADEMIC & RESEARCH INSTITUTES SEGMENT TO DOMINATE THE CELL SURFACE MARKERS MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: ASIA IS THE FASTEST-GROWING REGION IN THE CELL SURFACE MARKERS MARKET
  • FIGURE 18: CELL SURFACE MARKERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 19: ANTIBODIES SEGMENT WILL CONTINUE TO DOMINATE THE CELL SURFACE MARKER PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: MICE SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE CELL SURFACE MARKER ANTIBODIES MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: T CELL SURFACE MARKERS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: RESEARCH APPLICATIONS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL SURFACE MARKERS MARKET IN 2018
  • FIGURE 23: HOSPITALS & CLINICAL TESTING LABORATORIES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 24: NORTH AMERICA: CELL SURFACE MARKERS MARKET SNAPSHOT
  • FIGURE 25: EUROPE: CELL SURFACE MARKERS MARKET SNAPSHOT
  • FIGURE 26: ASIA: CELL SURFACE MARKERS MARKET SNAPSHOT
  • FIGURE 27: ROW: CELL SURFACE MARKERS MARKET SNAPSHOT
  • FIGURE 28: KEY DEVELOPMENTS IN THE CELL SURFACE MARKERS MARKET (JAN 2016-NOV 2018)
  • FIGURE 29: MARKET EVOLUTION FRAMEWORK
  • FIGURE 30: CELL SURFACE MARKERS MARKET RANKING ANALYSIS, BY KEY PLAYER (2017)
  • FIGURE 31: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC (2017)
  • FIGURE 32: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017)
  • FIGURE 33: COMPANY SNAPSHOT: ABCAM (2018*)
  • FIGURE 34: COMPANY SNAPSHOT: QIAGEN N.V. (2017)
  • FIGURE 35: COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE AG (2017)
  • FIGURE 36: COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2017)
  • FIGURE 37: COMPANY SNAPSHOT: DANAHER CORPORATION (2017)
  • FIGURE 38: COMPANY SNAPSHOT: GENSCRIPT (2017)
  • FIGURE 39: COMPANY SNAPSHOT: BIO-TECHNE (2017)
  • FIGURE 40: COMPANY SNAPSHOT: MERCK KGAA (2017)
Back to Top